Having secured $11.1 million in funding from Founders Fund, Lux Capital, Tenaya Capital, and Melo7 Tech Partners, Sols hopes to change the way you walk with 3D-printed insoles. Currently Sols only distributes its custom insoles in partnership with doctors, but founder Kegan Schouwenburg says the new funds will enable the company to launch a far cheaper direct-to-consumer product. Continue reading… “Sols aims for Dr. Scholl’s with 3D-printed insoles”
